These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21334185)

  • 1. The prospect of implementing a Safer Injection Facility in San Francisco: perspectives of community stakeholders.
    Wenger LD; Arreola SG; Kral AH
    Int J Drug Policy; 2011 May; 22(3):239-41. PubMed ID: 21334185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
    Kerr T; Small W; Moore D; Wood E
    Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of safer injection facilities in reducing HIV and hepatitis C infections and overdose mortality in the United States.
    Semaan S; Fleming P; Worrell C; Stolp H; Baack B; Miller M
    Drug Alcohol Depend; 2011 Nov; 118(2-3):100-10. PubMed ID: 21515001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in injecting practices associated with the use of a medically supervised safer injection facility.
    Stoltz JA; Wood E; Small W; Li K; Tyndall M; Montaner J; Kerr T
    J Public Health (Oxf); 2007 Mar; 29(1):35-9. PubMed ID: 17229788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambivalence about supervised injection facilities among community stakeholders.
    Strike C; Watson TM; Kolla G; Penn R; Bayoumi AM
    Harm Reduct J; 2015 Aug; 12():26. PubMed ID: 26292715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobile safe injecting facilities in Barcelona and Berlin.
    Dietze P; Winter R; Pedrana A; Leicht A; Majó I Roca X; Brugal MT
    Int J Drug Policy; 2012 Jul; 23(4):257-60. PubMed ID: 22464795
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia.
    Salmon AM; van Beek I; Amin J; Kaldor J; Maher L
    Addiction; 2010 Apr; 105(4):676-83. PubMed ID: 20148794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative evaluation of a peer-based needle syringe programme in Vietnam.
    Ngo AD; Schmich L; Higgs P; Fischer A
    Int J Drug Policy; 2009 Mar; 20(2):179-82. PubMed ID: 18242971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability of a safer injection facility among injection drug users in San Francisco.
    Kral AH; Wenger L; Carpenter L; Wood E; Kerr T; Bourgois P
    Drug Alcohol Depend; 2010 Jul; 110(1-2):160-3. PubMed ID: 20303679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of supervised injection facilities and injection risk behaviours among young drug injectors.
    Bravo MJ; Royuela L; De la Fuente L; Brugal MT; Barrio G; Domingo-Salvany A;
    Addiction; 2009 Apr; 104(4):614-9. PubMed ID: 19215603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 21st-century Lazarus: the role of safer injection sites in harm reduction and recovery.
    Strathdee SA; Pollini RA
    Addiction; 2007 Jun; 102(6):848-9. PubMed ID: 17523973
    [No Abstract]   [Full Text] [Related]  

  • 12. Soft tissue infections among injection drug users--San Francisco, California, 1996-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 May; 50(19):381-4. PubMed ID: 11465906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs).
    Strike C; Watson TM; Lavigne P; Hopkins S; Shore R; Young D; Leonard L; Millson P
    Int J Drug Policy; 2011 Jan; 22(1):34-40. PubMed ID: 20413288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study.
    Small W; Wood E; Lloyd-Smith E; Tyndall M; Kerr T
    Drug Alcohol Depend; 2008 Nov; 98(1-2):159-62. PubMed ID: 18650034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to health and social services for IDU: the impact of a medically supervised injection facility.
    Small W; Van Borek N; Fairbairn N; Wood E; Kerr T
    Drug Alcohol Rev; 2009 Jul; 28(4):341-6. PubMed ID: 19594786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do supervised injecting facilities attract higher-risk injection drug users?
    Wood E; Tyndall MW; Li K; Lloyd-Smith E; Small W; Montaner JS; Kerr T
    Am J Prev Med; 2005 Aug; 29(2):126-30. PubMed ID: 16005809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circumstances of first injection among illicit drug users accessing a medically supervised safer injection facility.
    Kerr T; Tyndall MW; Zhang R; Lai C; Montaner JS; Wood E
    Am J Public Health; 2007 Jul; 97(7):1228-30. PubMed ID: 17538061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safer injection facilities (SIFs) for injection drug users (IDUs) in Canada. A review and call for an evidence-focused pilot trial.
    Fischer B; Rehm J; Kim G; Robins A
    Can J Public Health; 2002; 93(5):336-8. PubMed ID: 12353452
    [No Abstract]   [Full Text] [Related]  

  • 20. Community attitudes towards harm reduction services and a newly established needle and syringe automatic dispensing machine in an inner-city area of Sydney, Australia.
    White B; Haber PS; Day CA
    Int J Drug Policy; 2016 Jan; 27():121-6. PubMed ID: 26118798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.